Neurotoxicity of cancer treatment

Current Oncology Reports

Volumn 12, Issue 1, 2010, Pages 60-67

  Chamberlain, Marc C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cancer treatment; Central and peripheral neurotoxicity

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; BORTEZOMIB; CAPECITABINE; CARBOPLATIN; CISPLATIN; CYCLOSPORIN; CYTARABINE; DOCETAXEL; EPOTHILONE DERIVATIVE; FLUOROURACIL; IFOSFAMIDE; IXABEPILONE; LENALIDOMIDE; METHOTREXATE; NAVELBINE; OXALIPLATIN; PACLITAXEL; RETINOID DERIVATIVE; SORAFENIB; STEROID; SUNITINIB; TACROLIMUS; TEMOZOLOMIDE; THALIDOMIDE; VINCRISTINE;

ASEPTIC MENINGITIS; ATAXIA; BEHAVIOR DISORDER; BRAIN DISEASE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN METASTASIS; BRAIN RADIATION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER SURVIVAL; CANCER THERAPY; CRANIOTOMY; CUSHINGOID SYNDROME; DIPLOPIA; DISEASE COURSE; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSARTHRIA; DYSMETRIA; GLIOBLASTOMA; GLIOMA; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSOMNIA; INTRACRANIAL PRESSURE; LEUKOENCEPHALOPATHY; MENTAL DISEASE; MYOPATHY; NAUSEA; NEUROPATHY; NEUROTOXICITY; NYSTAGMUS; PARANEOPLASTIC SYNDROME; PERIPHERAL NEUROPATHY; PHOTOPHOBIA; POSTOPERATIVE COMPLICATION; PSEUDOTUMOR; QUALITY OF LIFE; RADIATION INJURY; REVIEW; SEIZURE; SIDE EFFECT; SPINAL CORD DISEASE; TINNITUS; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL DISORDER; VOMITING; WEIGHT GAIN;

ANTINEOPLASTIC AGENTS; HUMANS; NEOPLASMS; NERVOUS SYSTEM DISEASES;

EID: 76749098044     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-009-0072-9     Document Type: Review

References (50)

1. S Ulmer TA Braga FG Barker, et al. 2006 Clinical and radiographic features of peritumoral infarction following resection of glioblastoma Neurology 67 1668 1670 10.1212/01.wnl.0000242894.21705.3c 1:STN:280: DC%2BD28nmslamug%3D%3D 17101902 (Pubitemid 44747942)
2. JS Smith S Cha MC Mayo, et al. 2005 Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury J Neurosurg 103 428 438 10.3171/jns.2005.103.3.0428 16235673
3. RB Khan PH Gutin SN Raj, et al. 2006 Use of diffusion weighted magnetic resonance imaging in predicting early postoperative outcome of new neurological deficits after brain tumor resection J Neurosurg 59 60 65 10.1227/01.NEU. 0000219218.43128.FC (Pubitemid 44024345)
4. SM Chang IF Parney M McDermott, et al. 2003 Perioperative complications and neurological outcomes for first and second craniotomies among patients enrolled in the Glioma Outcome Project J Neurosurg 98 1175 1181 10.3171/jns.2003.98.6.1175 12816260
5. NS Litofsky E Farace F Anderson Jr, et al. 2004 Depression in patients with high-grade glioma: results of the Glioma Outcomes Project Neurosurgery 54 358 366 10.1227/01.NEU.0000103450.94724.A2 14744282
6. RJ Jackson GN Fuller D Abi-Said, et al. 2001 Limitations of stereotactic biopsy in the initial management of gliomas Neuro Oncol 3 193 200 10.1215/15228517-3-3-193 1:STN:280:DC%2BD38%2Fit1GgsA%3D%3D 11465400
7. M Bernstein AG Parrent 1994 Complications of CT-guided stereotactic biopsy of intra-axial brain lesions J Neurosorg 81 165 168 10.3171/jns.1994.81. 2.0165 1:STN:280:DyaK2czgtVeluw%3D%3D
8. Leibel S, Sheline G: Tolerance of the brain and spinal cord to conventional irradiation. In Radiation Injury to the Nervous System. Edited by Gutin P LS, Sheline G. New York: Raven Press; 1991:239-256.
9. PJ Tofilon JR Fike 2000 The radioresponse of the central nervous system: a dynamic process Radiat Res 153 357 370 10.1667/0033-7587(2000)153[0357:TROTCN] 2.0.CO;2 1:CAS:528:DC%2BD3cXis1WrtL0%3D 10798963
10. Kim JH, Brown SL, Jenrow KA, Ryu S: Mechanisms of radiation-induced brain toxicity and implications for future clinical trials. J Neurooncol 2008, 87:279-286. This article provides an excellent overview of radiation injury of the brain.
11. C Belka W Budach RD Kortmann M Bamberg 2001 Radiation induced CNS toxicity-molecular and cellular mechanisms Br J Cancer 85 1233 1239 10.1054/bjoc.2001.2100 1:CAS:528:DC%2BD38XhsVemsw%3D%3D 11720454 (Pubitemid 33081913)
12. P New 2001 Radiation injury to the nervous system Curr Opin Neurol 14 725 734 10.1097/00019052-200112000-00008 1:STN:280:DC%2BD3Mnns1ymsg%3D%3D 11723380 (Pubitemid 34060109)
13. MC de Wit HG de Bruin W Eijkenboom, et al. 2004 Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression Neurology 63 535 537 15304589
14. MC Chamberlain MJ Glantz L Chalmers A Sloan 2007 Early necrosis following temodar and radiotherapy in patients with glioblastoma J Neuro Oncol 82 81 83 10.1007/s11060-006-9241-y (Pubitemid 46252277)
15. Brandsma D, Stalpers L, Taal W, et al.: Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 2008, 9:453-461. This article offers an excellent overview of pseudoprogression in high-grade gliomas treated with combined chemoradiation.
16. AA Brandes A Tosoni E Franceschi G Sotti, et al. 2009 Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation with MGMT promoter methylation status J Clin Oncol 27 1275 1279 10.1200/JCO.2008.19.4969 1:CAS:528: DC%2BD1MXktFKhsb4%3D 19188675
17. Y Yoshii 2008 Pathological review of late cerebral radionecrosis Brain Tumor Pathol 25 51 58 10.1007/s10014-008-0233-9 18987829
18. RJ Packer JG Gurney JA Punyko, et al. 2003 Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study J Clin Oncol 21 3255 3261 10.1200/JCO.2003.01.202 12947060 (Pubitemid 46606258)
19. AJ Kumar NE Leeds GN Fuller, et al. 2000 Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment Radiology 217 377 384 1:STN:280:DC%2BD3crhtFeqsg%3D%3D 11058631
20. KA Leber HG Eder H Kovac, et al. 1998 Treatment of cerebral radionecrosis by hyperbaric oxygen therapy Stereotact Funct Neurosurg 70 229 236 10.1159/000056426 9782255 (Pubitemid 28481416)
21. MJ Glantz PC Burger AH Friedman, et al. 1994 Treatment of radiation-induced nervous system injury with heparin and warfarin Neurology 44 2020 2027 1:STN:280:DyaK2M%2FlvF2rtw%3D%3D 7969953
22. Gonzalez J, Kumar AJ, Conrad CA, Levin VA: Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 2007, 67:323-326. This article discusses the first study to demonstrate an effective treatment, bevacizumab, for radiation-induced cerebral necrosis.
23. MA Weitzner CA Meyers K Bryne 1996 Psychosocial functioning and quality of life in patients with primary tumors J Neurosurg 84 29 34 10.3171/jns.1996.84.1.0029 1:STN:280:DyaK287htVyiuw%3D%3D 8613832
24. MJB Taphoorn R Stupp C Coens, et al. 2005 Health-related quality of life in patients with glioblastoma: a randomized controlled trial Lancet Oncol 6 937 944 10.1016/S1470-2045(05)70432-0 16321761 (Pubitemid 41685226)
25. CA Meyers JA Smith A Bezjak, et al. 2004 Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial J Clin Oncol 22 157 165 10.1200/JCO.2004.05.128 1:CAS:528:DC%2BD2cXpsVKhsrs%3D 14701778 (Pubitemid 41095128)
26. H Aoyama M Tago N Katoh, et al. 2007 Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone Int J Radiat Oncol Biol Phys 68 1388 1395 17674975
27. Li J, Bentzen SM, Renschler M, Mehta M: Regression after whole brain radiation therapy for brain metastases correlates with survival and improved neurocognitive outcome. J Clin Oncol 2007, 25:1260-1266. This article discusses a prospective trial indicating the importance of tumor response to radiation as a predictor of cognition in patients with brain metastases treated with whole brain radiotherapy.
28. CA Meyers PD Brown 2006 Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors J Clin Oncol 24 1305 1309 10.1200/JCO.2005.04.6086 16525186 (Pubitemid 46622034)
29. A Gregor A Cull RJ Stephens, et al. 1997 Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a Multicenter randomized trial: United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for research and treatment of Cancer (EORTC) Eur J Cancer 33 1752 1758 10.1016/S0959-8049(97)00135-4 1:STN:280:DyaK1c7jtFKjtg%3D%3D 9470828 (Pubitemid 28129199)
30. Wefel JS, Cloughesy TF, Zazzali J, et al. Neurocognitive function in patients with glioblastoma at first or second relapse treated with bevacizumab alone or in combination with irinotecan in the BRAIN study [abstract 338]. Neurooncology 2009, 11:641. This article offers a prospective evaluation of neurocognition in patients with recurrent glioblastoma treated with bevacizumab.
31. MJ Glantz MC Chamberlain Q Liu, et al. 2009 Gender disparity in the rate of partner abandonment in patients with serious medical illness Cancer 115 5237 5242 10.1002/cncr.24577 19645027
32. SM Nimjee CJ Powers KR Bulsara, et al. 2009 Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy Neurosurg Focus 21 e4
33. L Recht M Mrugala 2003 Neurologic complications of hematologic neoplasms Neurol Clin N Am 21 87 105
34. SR Plotkin PY Wen 2003 Neurologic complications of cancer therapy Neurol Clin N Am 21 279 318
35. MR Gilbert 1998 The neurotoxicity of chemotherapy Neurologist 4 43 53 10.1097/00127893-199803000-00001
36. AA Pruitt 2003 Nervous system infections in patients with cancer Neurol Clin N Amer 21 193 219
37. J Hinchey C Chaves B Appignani, et al. 1996 A reversible posterior leukoencephalopathy syndrome N Engl J Med 334 494 500 10.1056/ NEJM199602223340803 1:STN:280:DyaK287lslSisQ%3D%3D 8559202 (Pubitemid 26067737)
38. RH Herzig 1987 Hines, Herzig GP, et al.: Cerebellar toxicity with high-dose cytosine arabinoside J Clin Oncol 5 927 932 1:STN:280: DyaL2s3isFWitQ%3D%3D 3585447
39. MS Rosenfeld A Pruitt 2006 Neurologic complications of bone marrow, stem cell, and organ transplantation in patients with cancer Semin Oncol 33 352 361 10.1053/j.seminoncol.2006.03.003 16769425 (Pubitemid 43849926)
40. Vardy J, Wefel JS, Ahles T, et al.: Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 2008, 19:623-629. This article offers an excellent overview of chemotherapy-related cognitive dysfunction.
41. IF Tannock TA Ahles PA Ganz FS van Dam 2004 Cognitive impairment associated with chemotherapy for cancer: report of a workshop J Clin Oncol 22 2233 2239 10.1200/JCO.2004.08.094 15169812 (Pubitemid 41095159)
42. MC Chamberlain PA Kormanik D Barba 1997 Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases J Neurosurgery 87 694 699 10.3171/jns.1997.87.5.0694 1:STN:280: DyaK1c%2Fgs1ajsg%3D%3D
43. MJ Glantz KA Jaeckle MC Chamberlain, et al. 1999 A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors Clin Cancer Res 5 3394 3402 1:CAS:528:DyaK1MXotV2gsL0%3D 10589750
44. DA Loblaw J Perry A Chambers NJ Laperriere 2005 Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group J Clin Oncol 23 2028 2037 10.1200/JCO.2005.00.067 15774794 (Pubitemid 46211383)
45. Dalmau J, Rosenfeld MR: Paraneoplastic neurologic syndromes. In Harrison's Principles of Internal Medicine. Edited by Kasper DL, Braunwald E, Fauci AS, et al. New York: McGraw-Hill; 2005:571-575.
46. SH Kori KM Foley JB Posner 1981 Brachial plexus lesions in patients with cancer: 100 cases Neurology 31 45 50 1:STN:280:DyaL3M%2FpvFaksQ%3D%3D 6256684
47. RH Dworkin RW Johnson J Breuer, et al. 2007 Recommendations for the management of herpes zoster Clin Infect Dis 44 S1 S26 10.1086/510206 1:CAS:528:DC%2BD2sXmt12gsA%3D%3D 17143845 (Pubitemid 44956795)
48. S Quasthoff HP Hartung 2002 Chemotherapy-induced peripheral neuropathy J. Neurol 249 9 17 10.1007/PL00007853 1:CAS:528:DC%2BD38XisVKkt7k%3D 11954874
49. RW Gregg JM Molepo VJ Monpetit, et al. 1992 Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity J Clin Oncol 10 795 803 1:CAS:528:DyaK38Xks1ansbs%3D 1569451
50. J Owczarek M Jasinska D Orszulak-Michalak 2005 Drug-induced myopathies: an overview of the possible mechanisms Pharmacol Rep 57 23 34 1:CAS:528:DC%2BD2MXnsl2qsbg%3D 15849374